Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers.
about
Methodologies for localizing loco-regional hypopharyngeal carcinoma recurrences in relation to FDG-PET positive and clinical radiation therapy target volumes.Patterns of local-regional recurrence after conformal and intensity-modulated radiotherapy for head and neck cancer.18F-deoxyglucose positron emission tomography/computed tomography to predict local failure in esophageal squamous cell carcinoma.Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancerCan FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study.Recurrences after intensity modulated radiotherapy for head and neck squamous cell carcinoma more likely to originate from regions with high baseline [18F]-FDG uptakePredicting outcomes in radiation oncology--multifactorial decision support systemsEstimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local controlClinical Applications of FDG PET and PET/CT in Head and Neck Cancer.Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.Radiation dose escalation based on FDG-PET driven dose painting by numbers in oropharyngeal squamous cell carcinoma: a dosimetric comparison between TomoTherapy-HA and RapidArc.Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.FDG-PET, a Complementary Modality to Computed-Tomography in Radiotherapy Target Volume Delineation for Head and Neck Cancer.PET imaging biomarkers in head and neck cancer.The role of PET-CT in radiotherapy planning of solid tumours.Long-term outcome of (18) F-fluorodeoxyglucose-positron emission tomography-guided dose painting for head and neck cancer: Matched case-control study.Methodology for adaptive and robust FDG-PET escalated dose painting by numbers in head and neck tumors.Using spatial information about recurrence risk for robust optimization of dose-painting prescription functions.The clinical outcome correlations between radiation dose and pretreatment metabolic tumor volume for radiotherapy in head and neck cancer: A retrospective analysis.Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.Predictive value of pre-therapy (18)F-FDG PET/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer.Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions.Influence of volumetric 4'-[methyl-11C]-thiothymidine PET/CT parameters for prediction of the clinical outcome of head and neck cancer patients.Correlation between pretreatment FDG-PET biological target volume and location of T-site failure after definitive radiation therapy for head and neck cancers.Matched cohort analysis of the effect of pretreatment positron emission tomography on clinical outcomes of patients with head and neck cancer treated with definitive chemoradiotherapy.Assessment of tumor hypoxia by 62Cu-ATSM PET/CT as a predictor of response in head and neck cancer: a pilot study.Assessing hypoxia in animal tumor models based on pharmocokinetic analysis of dynamic FAZA PET.Use of baseline 18F-FDG PET scan to identify initial sub-volumes with local failure after concomitant radio-chemotherapy in head and neck cancer.Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy18F-FDG PET-CT in the Management of Patients Receiving Definitive Radiotherapy for Malignancies of the Head and Neck
P2860
Q33689901-94670B01-77AB-4A4A-9159-61212C764186Q33726601-CBF342C5-4C3D-4C30-AB92-BF4BB35C29B2Q33798433-BF3595A1-AB98-4FF3-8DCA-11A495ADDE75Q34596781-65B22EEF-7A45-4FFE-AC95-F1F62C1A936DQ35078927-CA985E4C-59A8-4D5C-A1B8-A74E42C31B48Q35747345-A3AB90B5-2A90-42E6-8A3B-A379A29C190AQ36014711-D94AE400-3122-4A4A-8D50-56E5933266A5Q36770099-2ED72337-D552-413F-86F6-0CFFFA168EA2Q37314625-FF01A4D5-BDDD-4505-89C6-0728D5EE1312Q37333035-F2300154-0456-4558-AEE0-DACDC16809DEQ37719626-E2D173D9-956D-4621-B95C-4071EF4AD15CQ38134094-0BA6BFAB-CCD8-4CA8-8C84-E02B00842574Q38157965-67977AD8-7A48-4432-AC3E-D7E1AAC713C1Q38312362-67F822F9-89B7-4770-87A7-A691553B44D7Q38391624-377A2CF6-7189-4AD8-8AA7-937A86F599B8Q38398891-30ED0F2C-245F-46E3-BD0F-77DB707085CCQ38414202-F5D8734B-EF74-4F5A-A916-48D12CFA17D6Q38432861-20258ECA-CBF7-4E1C-A68B-CE32E3D39919Q38704691-291CE59E-8746-4A88-BEE8-A0D032679ADFQ47692533-C8F79970-86A8-44CA-989F-6378CA2A4F01Q48099236-901233D2-7980-49E2-968C-8330BDF0AEE3Q48932198-C3FC3FA9-A64D-49B0-9363-17E0B8D3A300Q49896415-F9BD7281-7591-4086-A0F1-E5345E7833B9Q50084052-AF91183D-98FB-492A-80C9-6D0F3F6EC368Q51814005-ED8B9E05-444A-4FE5-BE21-C72AE2523D60Q52970700-FF9A5141-6F1C-4D2D-B1A1-1051896FF055Q52990736-39CC8285-EC76-4EA2-A1B8-4C355EEB6D7FQ53207205-C41F4FBF-22EC-4726-A608-FDFF542776D6Q53243969-BB6FC26C-8416-43AD-B6A8-3A0A2DEEBDC2Q53273186-974B9A4B-323E-4CF0-8C47-93A2246981F8Q55215317-6D2F6C96-A965-47F1-8D7F-DA9166EA33BDQ58814272-B9C90726-9106-4579-A32F-595B6272C1D4Q59104230-3F6C8E3D-0168-4370-AABC-BE63F47A3338
P2860
Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Correlation between pretreatme ...... apy for head and neck cancers.
@en
Correlation between pretreatme ...... apy for head and neck cancers.
@nl
type
label
Correlation between pretreatme ...... apy for head and neck cancers.
@en
Correlation between pretreatme ...... apy for head and neck cancers.
@nl
prefLabel
Correlation between pretreatme ...... apy for head and neck cancers.
@en
Correlation between pretreatme ...... apy for head and neck cancers.
@nl
P2093
P2860
P1476
Correlation between pretreatme ...... apy for head and neck cancers.
@en
P2093
Daniel E Soto
Marc L Kessler
Morand Piert
P2860
P356
10.1016/J.RADONC.2008.05.021
P577
2008-06-12T00:00:00Z